T46.4X6

Clinical Causes: Physician's cautious approach to avoid potential side effects like hypotension or kidney problems Patient's intolerance or sensitivity to higher doses of ACE inhibitors Lack of optimal medication titration or adjustment over time Patient non-adherence or reluctance to increase medication dosage Limited access or affordability of higher doses of medication Prescriber’s lack of familiarity with individual patient needs or response

Key Symptoms: Persistent high blood pressure despite medication use Symptoms of uncontrolled heart failure such as swelling, fatigue, or shortness of breath Potential side effects associated with ACE inhibitors at higher doses, including cough or dizziness, which may discourage dose escalation Lack of improvement in conditions typically treated with ACE inhibitors

Diagnosis Path: Diagnosis of underdosing is typically determined through a review of the patient’s medical history and medication regimen. Healthcare providers assess whether the prescribed dose aligns with standard treatment guidelines and the patient's therapeutic response. Blood pressure readings, laboratory tests (such as kidney function tests and electrolyte levels), and patient symptom reports are utilized to evaluate whether the medication dose is adequate or needs adjustment.

Treatment Protocols: Addressing underdosing involves careful medication management. Healthcare providers may consider gradually increasing the dose of ACE inhibitors to the optimal therapeutic level while monitoring for side effects. Regular follow-up appointments include tracking blood pressure, assessing for adverse reactions, and adjusting the dosage accordingly. Patient education on the importance of medication adherence and awareness of potential side effects is vital. In some cases, alternative or additional therapies may be recommended to better manage the condition.